Videos
Press Releases
Latest Newsletters
News
30 May 2023
Synthesis of minimally important differences for interpreting EORTC QLQ-C30 change scores across nine cancer types
25 May 2023
Publication of 2022 EORTC Annual Report
19 May 2023
EORTC is supporting Clinical Trials Day on 20th May
10 May 2023
Studying long-term survivors of glioblastoma may pave the way to better treatment
24 Apr 2023
Three new EORTC clinical trials funded by the EU
14 Apr 2023
Important new results from EORTC to be presented at ESTRO 2023
22 Feb 2023
HMP Global and EORTC announce partnership for the 25th annual World Congress on Gastrointestinal Cancer
31 Jan 2023
First international recommendations on the use of item libraries for patient-reported outcome measurement
30 Jan 2023
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients with Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
19 Dec 2022
Completion of Patient Recruitment for International TIGER Study